This inventor holds 1 USPTO granted patent. Top assignee: Biomaterials Universe, Inc.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Innovations of Yoshita Ikada in Polylactic Acid Microspheres
Introduction
Yoshita Ikada is a notable inventor based in Uji, Japan. He has made significant contributions to the field of biomaterials, particularly in the development of polylactic acid type microspheres. His work focuses on creating innovative solutions that enhance the delivery of physiologically active substances.
Latest Patents
Yoshita Ikada holds 1 patent for his invention titled "Polylactic acid type microspheres containing physiologically active." This patent describes microspheres comprising polylactic acid and a water-soluble physiologically active substance. The microspheres have a mean particle size ranging from about 0.01 μm to 300 μm. They demonstrate a controlled release of the active substance, showing not more than 30% of an eluted amount based on the content of the active substance in the microspheres after 24 hours in an in vitro elution test. This innovative approach allows for the gradual release of the active substance over a period of more than one week, maintaining its activity without loss.
Career Highlights
Yoshita Ikada is associated with Biomaterials Universe, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of biomaterials, particularly in the application of polylactic acid in drug delivery systems.
Collaborations
Yoshita collaborates with Suong-Hyu Hyon, who is also involved in the research and development of biomaterials. Their partnership enhances the innovative potential of their projects and contributes to the advancement of the field.
Conclusion
Yoshita Ikada's contributions to the development of polylactic acid type microspheres represent a significant advancement in biomaterials. His innovative approach to drug delivery systems showcases the potential for improved therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile